Back to search

Aristotle University Of Thessaloniki (AUTH)

Μορφολογική, ανοσοϊστοχημική και μοριακή διερεύνηση των αναπλαστικών λεμφωμάτων (ALCL)

Abstract

dc:description

The systematic anaplastic lymphoma (ALCL) constitutes an infrequent type of T-cell lymphoma, which characteristically expresses the CD30/KM antigen. A high fraction of ALCL expresses the anaplastic lymphoma kinase (ALK). Primary cutaneous anaplastic lymphoma (C-ALCL) is a T-cell lymphoma, which belongs in the group of T-cell lymphoproliferative disorders. Recently, the ALCL, ALK+ constitutes an autonomous category in the newer WHO classification, where they were apart from the ALCL, ALK- group of tumors. The ALCL, ALK+ tumors show very often the chromosomal translocation t(2;5) (p23;q35) between the NPM and ALK genes that leads to the creation of the “chimeric” gene, NPM-ALK, that is capable to drive oncogenesis. Variant translocation involving ALK and other genes has also reported. The aim of present study was to investigate in a series of 45 cases ALCL biopsies, from 42 patients the profile of genetic/molecular changes in combination with classic parameters that studied in the ALCL. More specifically, the ALK1 protein expression with IHC, the presence of t(2;5)(p23;q35) with RT-PCR and the rearrangements and/or chromosomal aberrations of ALK gene with FISH. The chromosome 2 status was also investigated with the centromeric 2 FISH probe. PCR, for the presence of T-cell receptor γ clonality performed. Probes for the identification of mRNAs containing (Bplus) and lacking (Bdel) exons 7 and 8 of the hTERT were studied with RT-PCR and 1SH, while the hTERT protein with IHC. Cyclin D1 was investigated with simple-and-double IHC at the protein level using two monoclonal antibodies, cyclin D1 mRNA, with ISH and RT-PCR and the CCND1 gene with FISH. Besides the above-mentioned methods, in the case of CCND1, the FICTION method was also applied. Fascin and MUC-1 proteins were also investigated. The IHC and in situ techniques were realised in the majority of cases in TMA sections, a modem technique, which allowed an important reduction of cost, time, and tissue material. From our study resulted the following observations and conclusions: 1) The molecular techniques (RT-PCR and FISH) used for detection of abnormalities of ALK gene showed a very high specificity to detect positive cases that are negative in the IHC for ALK1. 2) The systemic ALCLs present often gain of chromosome 2 that can be observed with the FISH assay. 3) The chromosomal aberration concerning polysomy of CCND1 gene and trisomy/polysomy of chromosome 11 detected in ALCLs is probably a consequence of the commonly observed polyploidy in this group of tumors. 4) Cyclin D1 mRNA is often expressed in ALCL, mostly related to the presence of translocations involving the ALK gene and to systemic disease. 5) The observed aberrations concerning CCND1 gene and cyclin D1 mRNA do not result in the production of functional Cyclin D1 protein, which, therefore, does not seem to play a role in the proliferation of ALCL. 6) The present study provides evidence that a decline in the overall expression of the B-deleted hTERT variant is found in ALCL cells, and in a higher incidence in the ALK translocation positive subgroup. Given the generally good prognosis of ALK positive ALCL, it appears unlikely that hTERT expression in ALCL is related to the prognosis of these tumors. The absence of hTERT expression in more than one-third of ALK negative ALCL may help to further refine tumor categorization in this heterogeneous lymphoma group. Importantly, the data presented here on hTERT variant mRNA expression were obtained by in situ approaches that can be further used to study respective alterations in a variety of lymphomas, where hTERT assessment in tissue extracts with RT-PCR based methods is likely to produce erroneous results. 7) Fascin overexpression mainly in the systemic ALCL probably contributes in invasiveness and systemic disease. 8) We observed significant differences in expression of MUC-1 protein in ALCL affecting younger individuals (≤ 35 years of age) and between systemic ALCL, ALK+ and ALCL, ALK-. The absence of MUC-I is probably theoretically related with better biological behavior, due to low resistance in chemotherapeutic agents.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bobos, M.
  • Μπόμπος, Ματθαίος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19451

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bobos, M.; Μπόμπος, Ματθαίος. Μορφολογική, ανοσοϊστοχημική και μοριακή διερεύνηση των αναπλαστικών λεμφωμάτων (ALCL). Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/19451